Home/ Supplements/ Coq10/ CoQmax-100 ME

CoQmax-100 ME

product on market Softgel Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Coenzyme Q10 is a cofactor in mitochondrial energy production and acts as an antioxidant to protect cells from oxidative damage. Research provides moderate to strong evidence for its role in supporting cardiovascular health and cellular energy. Other listed components are standard nutritional values with no significant therapeutic impact.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for CoQmax-100 ME
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1.5 Gram(s) (2% DV)
100 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)

Other Ingredients

Proprietary blend of
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one softgel one to two times daily, or as directed by your healthcare practitioner. Optimal results may be achieved by consuming with meals that contain fat.

Warnings & Precautions

Consult your healthcare practitioner prior to use. Do not use if tamper seal is damaged.

Individuals taking medication should discuss potential interactions with their healthcare practitioner.

Storage: Keep closed in a cool, dry place out of reach of children.

Formulation Notes

CoQmax-100 ME is XYMOGEN's proprietary, micro-emulsified, 100 mg CoQ10 for convenient higher dosing. The formula offers unparalleled absorption and bioavailability . CoQmax-100 ME has been shown in clinical trials to be over eight times more absorbable than powdered CoQ10 and more than twice as bioavailable as oil-based or so-called "Nano"-dispersed formulas on the market. CoQmax-100 ME's proprietary multi-lipid carrier is a formulation that is unmatched for optimal utilization in the support of cardiovascular and energy-based health needs.

Does Not Contain: Wheat, gluten, corn, yeast, soy, dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, or artificial preservatives.

Proprietary micro-emulsified CoQ10

Additional Information

Professional use only Not for resale on third-party websites, including, but not limited to, Amazon and eBay.

Storage: Keep closed in a cool, dry place out of reach of children. Variations in temperature may cloud the softgels. This does not affect the formula's efficacy or safety. Do not refrigerate.

ePV

Exclusive professional formulas

Third-Party Verified GMP Compliant

This package is completely recyclable

Metadata

Product Details

UPC / SKU8 71149 00274 9
DSLD Entry Date2021-01-22
Product TypeNon-Nutrient/Non-Botanical
FormSoftgel Capsule
BrandXYMOGEN
DSLD ID240147
Data Updated2026-04-11
Research

Research Evidence

202
Research Sources
55
Avg Quality
86
Meta Analysis
62
Systematic Review
28
Rct
17
Clinical Trial
4
Regulatory Source
2
Other
1
Narrative Review
1
Openfda Safety
A Coenzyme Q10 for heart failure
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Cardioprotective interventions for cancer patients receiving anthracyclines
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis
Meta Analysis BMJ open 2021 PubMed DOI
A Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials
Meta Analysis Irish journal of medical science 2022 PubMed DOI
B Cardioprotective interventions for cancer patients receiving anthracyclines
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Meta Analysis Reproductive sciences (Thousand Oaks, Calif.) 2023 PubMed DOI
B Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials
Meta Analysis International journal of molecular sciences 2020 PubMed DOI
B Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis
Meta Analysis Journal of nutritional science 2025 PubMed DOI
B Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Coq10 →
Compare

Similar Products

CoQ10 200 mg
VitaCeutical Labs · Softgel Capsule
100
CoQ10 100 mg
VitaCeutical Labs · Softgel Capsule
100
ClearQ Clear Base E 400 IU With CoQ10 50 mg
Natural Factors · Softgel Capsule
100
ClearQ Clear Base E 400 IU With CoQ10 50 mg
Natural Factors · Softgel Capsule
100
Ubiquinol 50 mg
Bronson · Softgel Capsule
100
View all Coq10 products →
Coq10 research Best Coq10 All Coq10 products More from XYMOGEN View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.